LUNG Q2 2023 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena

LUNGPulmonx Corporation

$75M

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+23.3% YoY

Gross Profit

$13M74.1% margin

Operating Income

-$16M-95.6% margin

Net Income

-$16M-94.2% margin

EPS (Diluted)

$-0.43

QoQ Revenue Growth

+18.3%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$193M

Total Liabilities

$59M

Stockholders' Equity

$134M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$14M	+23.3%
Gross Profit	$13M	$10M	+22.2%
Operating Income	-$16M	-$14M	-14.1%
Net Income	-$16M	-$15M	-10.6%

Geographic Segments

UNITED STATES

$11M64%

EMEA

$5M31%

Asia Pacific

$792,0005%

Other International Geographical Areas

$68,0000%